Jiangsu Hanbon Science and Technology
688755
ZERUN CO., LTD
301636
SENXUAN
830946
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
US Stock MarketDetailed Quotes
ADM Archer Daniels Midland
- 48.860
- -0.550-1.11%
Close May 15 16:00 ET
23.47BMarket Cap17.20P/E (TTM)
49.195High47.610Low4.18MVolume49.110Open49.410Pre Close202.51MTurnover0.88%Turnover Ratio13.39P/E (Static)480.45MShares64.19052wk High1.06P/B23.21BFloat Cap40.98052wk Low2.01Dividend TTM475.12MShs Float91.536Historical High4.11%Div YieldTTM3.21%Amplitude4.490Historical Low48.474Avg Price1Lot Size
Archer Daniels Midland Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.65%20.18B | -8.95%85.53B | -6.44%21.5B | -8.10%19.94B | -11.68%22.25B | -9.24%21.85B | -7.50%93.94B | -11.42%22.98B | -12.11%21.7B | -7.67%25.19B |
| Operating revenue | -7.65%20.18B | -8.95%85.53B | -6.44%21.5B | -8.10%19.94B | -11.68%22.25B | -9.24%21.85B | -7.50%93.94B | -11.42%22.98B | -12.11%21.7B | -7.67%25.19B |
| Cost of revenue | -5.91%19B | -7.72%79.75B | -5.17%20.14B | -6.60%18.57B | -10.53%20.85B | -8.20%20.19B | -8.05%86.42B | -12.16%21.24B | -13.06%19.89B | -7.45%23.31B |
| Gross profit | -28.87%1.18B | -23.09%5.78B | -21.95%1.36B | -24.59%1.37B | -25.86%1.4B | -20.24%1.66B | -0.75%7.51B | -1.25%1.74B | -0.06%1.81B | -10.33%1.88B |
| Operating expense | -2.00%932M | 7.23%3.71B | 2.61%943M | 11.04%905M | 7.85%907M | 7.95%951M | 2.92%3.46B | 2.45%919M | -0.37%815M | 3.32%841M |
| Selling and administrative expenses | -2.00%932M | 7.23%3.71B | 2.61%943M | 11.04%905M | 7.85%907M | 7.95%951M | 2.92%3.46B | 2.45%919M | -0.37%815M | 3.32%841M |
| Operating profit | -64.97%248M | -48.93%2.07B | -49.45%415M | -53.77%460M | -53.07%489M | -40.95%708M | -3.68%4.06B | -5.09%821M | 0.20%995M | -18.97%1.04B |
| Net non-operating interest income expense | 53.49%-20M | 2.70%-144M | 81.91%-17M | -1,133.33%-37M | -23.68%-47M | -230.77%-43M | -43.69%-148M | -452.94%-94M | 75.00%-3M | 7.32%-38M |
| Non-operating interest income | 12.20%138M | 12.63%562M | 128.17%162M | -9.87%137M | -1.41%140M | -8.21%123M | 70.31%499M | -39.32%71M | 78.82%152M | 343.75%142M |
| Non-operating interest expense | -4.82%158M | 9.12%706M | 8.48%179M | 12.26%174M | 3.89%187M | 12.93%166M | 63.38%647M | 23.13%165M | 59.79%155M | 146.58%180M |
| Other net income (expense) | -43.18%125M | -15.06%327M | 3,742.86%269M | -907.69%-315M | 20.31%154M | 4.27%220M | -65.75%385M | -98.08%7M | -84.34%39M | -53.28%128M |
| Earnings from equity interest | -32.08%144M | 12.70%621M | -13.99%123M | 61.45%134M | 0.66%152M | 21.84%212M | -33.77%551M | -36.73%143M | -60.48%83M | -21.35%151M |
| Special income (charges) | -87.50%-30M | -70.39%-518M | 103.66%7M | -550.00%-507M | 94.87%-2M | -500.00%-16M | -2,633.33%-304M | -9,650.00%-191M | -1,214.29%-78M | -1,075.00%-39M |
| -Less：Restructuring and merger&acquisition | 153.33%38M | -21.21%26M | ---- | ---- | ---- | 275.00%15M | 13.79%33M | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --0 | 67.96%519M | ---- | ---- | ---- | 0.00%3M | 735.14%309M | ---- | ---- | ---- |
| -Write off | ---- | ---- | ---- | 541.77%507M | -88.33%7M | ---- | ---- | ---- | 182.14%79M | 5,900.00%60M |
| -Gain on sale of property,plant,equipment | 300.00%8M | -28.95%27M | 300.00%20M | --0 | -76.19%5M | -81.82%2M | -51.28%38M | -86.84%5M | -97.14%1M | 320.00%21M |
| Other non- operating income (expenses) | -54.17%11M | 62.32%224M | 152.73%139M | 70.59%58M | -75.00%4M | -27.27%24M | -50.71%138M | -59.85%55M | 6.25%34M | -79.49%16M |
| Income before tax | -60.11%353M | -47.48%2.26B | -9.13%667M | -89.52%108M | -47.35%596M | -36.65%885M | -17.94%4.29B | -39.49%734M | -16.18%1.03B | -25.48%1.13B |
| Income tax | -63.25%61M | -42.51%476M | -44.79%106M | -56.52%90M | -43.63%115M | -26.22%166M | -4.61%828M | 1.59%192M | 7.25%207M | -26.88%204M |
| Net income | -59.39%292M | -48.67%1.78B | 3.51%561M | -97.82%18M | -48.17%481M | -38.65%719M | -20.60%3.47B | -47.07%542M | -20.54%824M | -25.16%928M |
| Net income continuous Operations | -59.39%292M | -48.67%1.78B | 3.51%561M | -97.82%18M | -48.17%481M | -38.65%719M | -20.60%3.47B | -47.07%542M | -20.54%824M | -25.16%928M |
| Minority interest income | 70.00%-3M | -23.53%-21M | 73.91%-6M | 0 | -600.00%-5M | -600.00%-10M | -168.00%-17M | -560.00%-23M | -50.00%3M | -75.00%1M |
| Net income attributable to the parent company | -59.53%295M | -48.32%1.8B | 0.35%567M | -97.81%18M | -47.57%486M | -37.69%729M | -19.75%3.48B | -44.55%565M | -20.37%821M | -25.00%927M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -59.53%295M | -48.32%1.8B | 0.35%567M | -97.81%18M | -47.57%486M | -37.69%729M | -19.75%3.48B | -44.55%565M | -20.37%821M | -25.00%927M |
| Basic earnings per share | -57.04%0.61 | -43.17%3.66 | 9.83%1.1862 | -97.37%0.04 | -41.76%0.99 | -33.33%1.42 | -16.58%6.44 | -42.03%1.08 | -17.39%1.52 | -22.02%1.7 |
| Diluted earnings per share | -57.04%0.61 | -43.23%3.65 | 8.33%1.17 | -97.37%0.04 | -42.35%0.98 | -33.02%1.42 | -16.60%6.43 | -41.30%1.08 | -16.94%1.52 | -22.02%1.7 |
| Dividend per share | 2.00%0.51 | 11.11%2 | 11.11%0.5 | 11.11%0.5 | 11.11%0.5 | 11.11%0.5 | 12.50%1.8 | 12.50%0.45 | 12.50%0.45 | 12.50%0.45 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀